Search the MBS

Related Items: 73295 73296 73297 73300 73304 73305 73333 73334 73339 73340 73392 73393 73394 73395 73416 73417 73418 73419 73440 73441 73442 73443 73444

• Previous - Note PN.0.22
• Next - Note PN.0.24

Characterisation of germline gene variants, including copy number variation where appropriate, requested by a specialist or consultant physician:

(a) in genes associated with breast, ovarian, fallopian tube or primary peritoneal cancer, which must include at least:

(i) BRCA1 and BRCA 2 genes; and

(ii) one or more STK11, PTEN, CDH1, PALB2 and TP53 genes; and

(b) in a patient:

(i) with breast, ovarian, fallopian tube or primary peritoneal cancer; and

(ii) for whom clinical and family history criteria place the patient at greater than 10% risk of having a pathogenic or likely pathogenic gene associated with breast, ovarian, fallopian tube or primary peritoneal cancer

Once per cancer diagnosis

Fee: $1,200.00 Benefit: 75% = $900.00 85% = $1,101.30

(See para PN.0.23 of explanatory notes to this Category)

• Previous - Item 73295
• Next - Item 73297

Characterisation of germline gene variants, including copy number variation where appropriate, requested by a specialist or consultant physician:

(a) in genes associated with breast, ovarian, fallopian tube or primary peritoneal cancer, which may include the following genes:

(i) BRCA1 or BRCA2;

(ii) STK11, PTEN, CDH1, PALB2 and TP53; and

(b) in a patient:

(i) who has a biological relative who has had a pathogenic or likely pathogenic gene variant identified in one or more of the genes mentioned in paragraph (a); or

(ii) who has not previously received a service to which item 73295, 73296 or 73302 applies

Once per variant

Fee: $400.00 Benefit: 75% = $300.00 85% = $340.00

(See para PN.0.23 of explanatory notes to this Category)

• Previous - Item 73296
• Next - Item 73298

Characterisation of germline gene variants including copy number variants, in BRCA1 or BRCA2 genes, in a patient who has had a pathogenic or likely pathogenic variant identified in either gene by tumour testing and who has not previously received a service to which items 73295, 73296 or 73297 applies, requested by a specialist or consultant physician.

Applicable once per primary tumour diagnosis

Fee: $400.00 Benefit: 75% = $300.00 85% = $340.00

• Previous - Item 73301
• Next - Item 73303